UNIVERSITE DE LORRAINE

A titanium alloy includes, in content by weight 4.0% to 5.0% aluminium; 3.50% to 4.50% tin; 1.0% to 4.0% zirconium; 2.0% to 5.25% molybdenum; 1.0% to 2.50% niobium; 0.10% to 0.25% silicon; 0.10% to 0.18% oxygen; the remainder being titanium and unavoidable impurities, the alloy further being such that the Aleq criterion, referred to as equivalent aluminium content by weight, is less than or equal to 8.5%, the Aleq criterion being defined as Aleq=[Al]+[Sn]/3+[Zr]/6+10*[O] where, [Sn], [Zr] and [O] are the contents by weight of aluminium, tin, zirconium and oxygen respectively.

A superconducting flux barrier electric machine, including one induced element and one inductor, the inductor including one superconducting induction coil and a rotary portion forming a rotor, and the induced element including one arrangement of electromagnetic coils coaxial with the superconducting induction coil, the rotor comprising superconducting pellets mounted radially inside the superconducting coil on an axis of rotation of the machine, where the electromagnetic coils are made of superconducting material and the induced element and the inductor are arranged in an assembly forming a cooling chamber provided with specific cooling means for the superconducting elements of the induced element and the inductor.

A spin-LED or spin-laser light emission system includes a stack including an active layer and transport layers, an electrode as anode and an electrode as cathode, a spin injector, deposited on the stack and including an assembly of at least one first layer made of ferromagnetic material and at least one second layer made of metal material, the assembly having a bar structure being a Hall bar, a first electrode and a second electrode, being spin electrodes, configured to generate, in the Hall bar, a pulsed current along the axis X in a first direction or a second direction opposite the first direction, the spin injector having a magnetization along Z and such that reversal of the direction of the current reverses the direction of the magnetization, switching of the magnetization of the spin injector inducing a change in the circular polarization state of light emitted by the emission system.

The invention relates to a muscle membrane intended to be affixed to a muscle of a human or animal body, the membrane being capable of at least partially surrounding the muscle, the muscle comprising fibres covered with an outer tissue, the positioned membrane having a shape that is identical to that of the muscle. The membrane is characterised in that it exhibits anisotropic behaviour so as to reproduce the mechanical behaviour of the muscle, the membrane comprising: -a matrix designed in a biocompatible material having an elasticity similar to that of the outer tissue of the muscle, -one or more reinforcing strips rigidly attached to the matrix, each strip being designed in a biocompatible material having an elasticity similar to that of the fibres it covers and each strip being oriented according to membrane stiffening requirements and according to the expected muscle correction.

An aircraft electric or hybrid propulsion architecture including at least two propulsion lines, each propulsion line including at least one electric motor supplied from at least two energy sources of the propulsion architecture through at least two energy supply paths, each energy supply path including at least one energy inverter, and one electrical protection delivering a DC voltage for a HVDC bus, each HVDC bus distributing this DC voltage to at least one electric motor through at least one energy inverter and one electrical protection, the propulsion architecture including at least partially dissimilar and preferably completely dissimilar energy supply paths.

The present invention relates to the treatment of an arthritic disease such as rheumatoid arthritis with a kynurenine aminotransferase, a living recombinant bacterium which has been genetically modified to express and secrete said kynurenine aminotransferase, and/or a product of said kynurenine aminotransferase which is xanthurenic acid, a derivative thereof, or any pharmaceutically acceptable salt or solvate thereof.

A process for producing a protein isolate from an oilseed meal, and the isolate thus obtained, said isolate comprising proteins and an amount of 4 wt % or less of phytic acid, said amount of phytic acid being by weight of proteins in said isolate. The process may comprise the following steps: a) providing an oilseed meal; b) mixing the oilseed meal with a first aqueous solvent to form a slurry at a pH ranging from 6 to 7.8, said slurry having a solid phase; c) separating said solid phase from said slurry, d) mixing said separated solid phase with a second aqueous solvent at a pH ranging from 1 to 3.5, preferably from 2 to 3, to form a mixture said mixture having a liquid phase; e) separating said liquid phase from said mixture formed in step d); f) f1) mixing the separated liquid phase to a phytase at a temperature and a pH suitable for phytase activity to obtain a mixture having a liquid phase and a solid phase; and/or f2) mixing the separated liquid to a salt, to obtain a resulting liquid composition having a molar concentration of said salt ranging from 0.05 M to 0.5 M, at a temperature ranging from 40° C. to 70° C., to obtain a mixture having a liquid phase and a solid phase; g) precipitating a solid phase from the liquid of step f) for example by a cooling down step of the mixture to a temperature of 30° C. or less; h) separating said solid precipitate from the liquid of step g) said liquid comprising a water-rich liquid phase and an oil-rich liquid phase; i) separating said water-rich liquid phase from said oil-rich liquid phase, j) subjecting said water-rich liquid phase obtained in step i) to one or several membrane filtration(s) to obtain a protein isolate; and k) optionally, drying said protein isolate to obtain a dry protein isolate.

The present invention relates to a fusion protein, to a nucleic acid coding for the protein, to a vector comprising the nucleic acid, to a host cell comprising the nucleic acid and/or vector, to a process for producing a fusion protein and to a process for bioconverting a substrate. The fusion protein of the present invention successively comprises (i) at least one polypeptide for targeting, and anchoring to, the bacterial membrane, (ii) at least one polypeptide corresponding to the hydrophilic domain of a plant P450 cytochrome, (iii) at least one binding polypeptide comprising at least 47 amino acids, and (iv) at least one polypeptide corresponding to the hydrophilic domain of a plant NADPH-dependent cytochrome P450 reductase.

Disclosed is a method for depositing a coating on inner surfaces forming cavities of a heat exchanger, characterized in that the coating comprises a liquid adhesive and a powder of a pulverulent solid intended to act as a catalyst for a physico-chemical reaction.

The present invention relates to the field of crop fertilization, and particularly to a biofertilizing bacterial strain. In particular, the present invention relates to the bacterial strain deposited on Oct. 24, 2018, at the Collection Nationale de Culture de Microorganismes (CNCM), 28 rue du Dr. Roux, 75724 PARIS CEDEX 15, under the Budapest Treaty under number CNCM I-5373, and to the uses of this strain. The invention also relates to a composition comprising the above-mentioned bacterial strain and to a fertilization process comprising the application of this composition to a plant or to a soil.